Normal view MARC view ISBD view

Statistical optimization and evaluation of a multi release unit bilayer tablet of rizatriptan benzoate

By: Reddy, Kavya Handenahalli Ramakrishna.
Contributor(s): Bhattacharyya, Sayani.
Publisher: Mumbai Indian Journal of Pharmaceutical Science 2021Edition: Vol.83(1), Jan-Feb.Description: 52-59p.Subject(s): PHARMACEUTICSOnline resources: Click here In: Indian journal of pharmaceutical sciencesSummary: Migraine, a neurological condition is often associated with intense, throbbing, crippling headaches for hours to days. Rizatriptan benzoate has established its potential in controlling the symptoms of migraine. The present study aims to formulate a bilayer tablet of rizatriptan with multi release unit matrix embedded in the sustained layer to achieve a pulsatile release of the drug to control the various phases of migraine. A preliminary study on four matrices-F1, F2, F3 and F4 with different proportion of carnauba wax and ethyl cellulose was done to evaluate the release pattern of rizatriptan in fasted state simulated intestinal fluid at pH 6.5. A simplex lattice design was used to find out the optimized ratio of the matrices to control the dissolution of rizatriptan benzoate in a predetermined fashion at different hour’s intervals. The release profile was optimized with a blend of three different formulations (F1:F2:F3=0.53:0.24:0.23). Statistical analysis revealed that the percentage error between the predicted and optimum blend was less than 5 %. The immediate release layer was formulated with direct compression method using super disintegrants. The evaluation of bilayer tablet was done for hardness, weight variation, friability, uniformity of content and percentage release. The tablet met the criteria of pharmacopoeial requirements. The bilayer tablet of rizatriptan benzoate could able to release the drug instantly as comparable with marketed immediate release tablet of rizatriptan benzoate and could also prolong the release for 24 h. The accelerated stability study also showed the tablets could retain their property at variable temperature and humidity. Therefore, it can be concluded that the bilayer tablet of rizatriptan benzoate embedded in a wax polymer multi release unit matrix has a potential to deliver the drug at a predetermined rate for the effective control of migrainee.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Status Date due Barcode Item holds
Articles Abstract Database Articles Abstract Database School of Pharmacy
Archieval Section
Not for loan 2021-2022624
Total holds: 0

Migraine, a neurological condition is often associated with intense, throbbing, crippling headaches for
hours to days. Rizatriptan benzoate has established its potential in controlling the symptoms of migraine.
The present study aims to formulate a bilayer tablet of rizatriptan with multi release unit matrix embedded
in the sustained layer to achieve a pulsatile release of the drug to control the various phases of migraine.
A preliminary study on four matrices-F1, F2, F3 and F4 with different proportion of carnauba wax and
ethyl cellulose was done to evaluate the release pattern of rizatriptan in fasted state simulated intestinal
fluid at pH 6.5. A simplex lattice design was used to find out the optimized ratio of the matrices to control
the dissolution of rizatriptan benzoate in a predetermined fashion at different hour’s intervals. The release
profile was optimized with a blend of three different formulations (F1:F2:F3=0.53:0.24:0.23). Statistical
analysis revealed that the percentage error between the predicted and optimum blend was less than 5 %.
The immediate release layer was formulated with direct compression method using super disintegrants.
The evaluation of bilayer tablet was done for hardness, weight variation, friability, uniformity of content
and percentage release. The tablet met the criteria of pharmacopoeial requirements. The bilayer tablet
of rizatriptan benzoate could able to release the drug instantly as comparable with marketed immediate
release tablet of rizatriptan benzoate and could also prolong the release for 24 h. The accelerated stability
study also showed the tablets could retain their property at variable temperature and humidity. Therefore,
it can be concluded that the bilayer tablet of rizatriptan benzoate embedded in a wax polymer multi
release unit matrix has a potential to deliver the drug at a predetermined rate for the effective control of
migrainee.

There are no comments for this item.

Log in to your account to post a comment.

Click on an image to view it in the image viewer

Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha